Скачать с ютуб Key considerations in viral clearance testing - Vironova Biosafety в хорошем качестве

Key considerations in viral clearance testing - Vironova Biosafety

A tutorial how to design a viral clearance study in respect of what virus removal or inactivation steps to include and what virus panel to use in the testing. It also explains the importance of keeping the process parameters true when down scaling and how to calculate the robustness of the virus clearance steps. Learn more at https://www.vironovabiosafety.com/ ABOUT VIRONOVA BIOSAFETY Vironova Biosafety is a contract research organization (CRO) specialized in performing viral clearance studies for biological drugs. The purpose of viral clearance studies is to evaluate the ability of a particular purification process used in pharmaceutical production to disable or eliminate potential viral contamination. It is mandatory to perform viral clearance validation on pharmaceutical purification processes where material of human or animal origin is used. Vironova Biosafety is the only Nordic CRO that conducts these studies in BSLII and BSLIII certified cell and virus laboratories and in compliance with good laboratory practices (GLP). Services range from early R&D to market release. Our office and laboratories are located in central Stockholm. Our customers can be found worldwide. The Vironova Biosafety team have a broad research background and experience of a wide range of biologics. We can help you to plan a specific study or solve a tricky problem. Whatever your need, you can contact us by sending an e-mail to [email protected] We’d love to hear from you.